Sam Salman

President at Gene Therapy Company

Sam Salman's Professional Contact Details

Email (Verified)

****

Get Email Address

(312) 441-1800

Location

New York, New York, US

Company

Gene Therapy Company

Person Seniority

Sam Salman's Current Company Details

Gene Therapy Company

New York, New York, US • 2 Employees

hospital & health care

Errant Gene Therapeutics, LLCâ„¢ (EGT) is a privately held biopharmaceutical company established in 2003. The company's mission is the development of treatments for life-threatening diseases with a special focus on rare diseases, commonly referred to as "orphan diseases." EGT is developing its portfolio of pharmaceutical products to correct the erroneous gene expression associated with many of these diseases. EGT therapies are currently being developed for hemoglobinopathies and selected cancers. EGT's product portfolio is the result of license agreements to technology for exclusive world-wide rights and the acquisition of a library of novel pharmaceutical molecules. Two products are poised to enter into clinical development.

Organization Website

errantgene.com

Organization Languages

English

Organization Revenue

2000

Current Technologies

amazon aws

nginx

facebook login

google analytics

wordpress org